Nuzenio

Tradingview Profound Medical

Tradingview Profound Medical news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 22:59:11 GMTPRN: Q2 revenue up 12% (153% adjusted), gross margin 78%, and pipeline at CAD 70 million - TradingView
Thu, 06 Aug 2026 20:35:07 GMTProfound Medical Corp. 2026: Revenue $2.48M, EPS ($0.26) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 20:34:06 GMTPRN: Revenue up 62% and net loss down 37% year-over-year, with gross margin rising to 74% - TradingView
Thu, 06 Aug 2026 20:22:21 GMTPRN: Q2-2026 saw 12% revenue growth, 78% gross margin, and improved net loss, with strong outlook - TradingView
Thu, 06 Aug 2026 20:13:31 GMTBRIEF-Profound Medical Q2 EPS USD -0.26 - TradingView
Thu, 30 Jul 2026 06:10:15 GMTPROF|Profound Medical Corp|Price:7.230|Chg%:-0.020 - TradingKey

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Profound Medical.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.